Page 2 - ECOS 2024 - PROGRAMME
P. 2

ANNUAL MEETING - 9  EDITION
                                                                   TH
                                          Saturday, November 30 , 2024 - 08:00 to 15:30
                                                             th
                                          Sheraton Amsterdam Airport Hotel


     •  ON NOVEMBER 29  - WELCOME DINNER - 20:00 at the hotel
                   th
     •  ON NOVEMBER 30 - ECOS-G MEETING - 8:00 to 15:30 at the hotel
                   th
                                MORNING SESSION - 8:00 to 12:30
    08:00 - 08:30 •  Introduction - What Has Happened Since the Last Meeting?
    08:30 - 11:25 •  Meeting the Challenges of Adherence in Glaucoma - Chaired by Prof. Stalmans (Belgium)
                 When Less Is Better: Optimizing topical treatment outcomes - By Prof. Kolko (Denmark)
              & Prof. Prokosch (Germany)
             •  Lectures
             •  Workshops by Table
             •  Restitution

                   Understanding Adherence to Improve It: an ECOS-G Delphi Consensus - By Prof. Hommer (Austria)
              & Prof. Tatham (UK)
    09:50 - 10:15 -  Coffee Break
                Seeing Eye to Eye: Individualizing Care in Glaucoma - By Prof. Cvenkel (Slovenia), Prof. Lanzl (Germany)
              & Dr. Meier-Gibbons (Switzerland)
     11:25- 12:30 •  Surgery vs. Topical Treatment for Glaucoma - Chaired by Prof. Baudouin (France)
               Surgery and Eye Drops: What about Ocular Surface? - By Prof. Van Setten (Sweden)
               Choosing First-line Treatment: SLT vs. Topical Treatments - By Prof. Abegao-Pinto (Portugal)
               Treatment Considerations Before and After SLT
               Discussion: the Position of SLT and Eye Drops in your practice - By Prof Baudouin (France)

    12:30 - 13:45 - Lunch break
                              AFTERNOON SESSION - 13:45 to 15:30

    13:45 - 15:05 •  An Eye on the Future of Glaucoma Practice - Chaired by Prof. Topouzis (Greece)
               Is AI a Game Changer for Glaucoma Management? - Chaired by Prof. Barton (UK)
             •  Deep-learning Methods for Diagnosis and Management: How AI Can Help? - By Prof. Schmetterer (Austria)
             •  Home-monitoring Tools: Where Are We? - By Prof. Barton (UK)
             •  Chatbots for Decision-making - By Prof. Schmetterer (Austria) & Prof. Stalmans (Belgium)
               Biomarkers for Ocular Surface & Glaucoma - Prof. Benitez-del-Castillo (Spain) & Dr. Maldonado (Mexico)
    15:05 - 15:30 • Restitution and Meeting Closing

                              International contacts
               Amandine ROCHE      Anna JANKOWSKA-JADCZAK    Claire DA COSTA
            Amandine.ROCHE@theapharma.com   anna.jankowska-jadczak@theapharma.com   Claire.DACOSTA@theapharma.com
               Tel.: +(33)6 40 49 89 84  Tel.: +(48)6 91 912 305  Tel. :  +(33) 6 79 43 41 24
  Subject to approval of the French National Council of the French Medical Professions. For the French healthcare professional, Laboratoires Théa shall declare to the medical council where the healthcare professional
  is registered the financial participation it covers for this healthcare professional. Moreover, according to Article 2 of the French law n°2011-2012 of 29 December 2011 and to Article 178 of the French law n°2016-41
  of 26 January 2016, it shall be publicly declared the interests it may have with French healthcare professionals (including financial terms) according to the applicable Decrees. For healthcare professionals based in
  another country, Laboratoires Théa shall comply with local applicable law and regulation regarding the declaration to a medical council or any competent entity where the healthcare professional is registered and
  with the reporting and declaration to a public audience or a competent authority of interests it may have with healthcare professionals.
   1   2   3